These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2666332

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Chloroquine retinopathy].
    François J, de Rouck A, Cambie E, de Laey JJ.
    Ophthalmologica; 1972; 165(2):81-99. PubMed ID: 4539289
    [No Abstract] [Full Text] [Related]

  • 4. Screening for antimalarial toxicity.
    Easterbrook M.
    Can J Ophthalmol; 1993 Apr; 28(2):51-2. PubMed ID: 8508335
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
    Marmor MF.
    Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ophthalmologic considerations in using antimalarials in the United States.
    Rynes RI.
    Lupus; 1996 Jun; 5 Suppl 1():S73-4. PubMed ID: 8803917
    [Abstract] [Full Text] [Related]

  • 9. Current concepts in monitoring patients on antimalarials.
    Easterbrook M.
    Aust N Z J Ophthalmol; 1998 May; 26(2):101-3. PubMed ID: 9630287
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ocular toxicity of antimalarial drugs. Long-term follow-up.
    Carr RE, Henkind P, Rothfield N, Siegel IM.
    Am J Ophthalmol; 1968 Oct; 66(4):738-44. PubMed ID: 5729592
    [No Abstract] [Full Text] [Related]

  • 12. Hydroxychloroquine retinopathy: A review of imaging.
    Pandya HK, Robinson M, Mandal N, Shah VA.
    Indian J Ophthalmol; 2015 Jul; 63(7):570-4. PubMed ID: 26458473
    [Abstract] [Full Text] [Related]

  • 13. RE: Microperimetry and the diagnosis of antimalarial maculopathy.
    Easterbrook M.
    Can J Ophthalmol; 2014 Jun; 49(3):307-8. PubMed ID: 24862782
    [No Abstract] [Full Text] [Related]

  • 14. Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study.
    Kobak S, Deveci H.
    Int J Rheum Dis; 2010 Aug; 13(3):e11-5. PubMed ID: 20704603
    [Abstract] [Full Text] [Related]

  • 15. [Routine monitoring of patients treated with synthetic antimalarials].
    Douche C, Bechetoille A, Ebran JM.
    J Fr Ophtalmol; 1983 Aug; 6(8-9):689-95. PubMed ID: 6677659
    [Abstract] [Full Text] [Related]

  • 16. [The cornea and synthetic antimalarials].
    Jeddi A, Ben Osman N, Daghfous F, Bouguila H, Charfi O, Ayed S.
    J Fr Ophtalmol; 1994 Aug; 17(1):36-8. PubMed ID: 8176172
    [Abstract] [Full Text] [Related]

  • 17. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB.
    Retina; 2008 Aug; 28(10):1478-86. PubMed ID: 18997610
    [Abstract] [Full Text] [Related]

  • 18. Detection and prevention of maculopathy associated with antimalarial agents.
    Easterbrook M.
    Int Ophthalmol Clin; 1999 Aug; 39(2):49-57. PubMed ID: 10343924
    [Abstract] [Full Text] [Related]

  • 19. [Ocular toxicity due to 4-aminoquinoline derivatives].
    Gouveia EB, Morales MS, Gouveia GB, Lourenzi VP.
    Arq Bras Oftalmol; 2007 Aug; 70(6):1046-51. PubMed ID: 18235926
    [Abstract] [Full Text] [Related]

  • 20. Is corneal deposition of antimalarial any indication of retinal toxicity?
    Easterbrook M.
    Can J Ophthalmol; 1990 Aug; 25(5):249-51. PubMed ID: 2207871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.